Upgrade to cardiac resynchronization therapy with a defibrillator (CRT-D) reduces morbidity and mortality and improves left ventricular (LV) reverse remodeling compared to an implantable ...

Please provide your email address to receive an email when new articles are posted on . Long-term CRT-D use was tied to improved survival and time to adverse events vs. ICD therapy in patients with ...

Cardiac device therapy has significantly evolved since the introduction of the first implantable pacemaker and the subsequent ...

CRT is a surgical procedure in which doctors implant a pacemaker in both the right and left sides of the heart to help your heart’s chambers beat together. The goal is to improve heart pumping ...

Receipt of a cardiac-resynchronization therapy-defibrillator (CRT-D) offers long term benefit for patients with heart failure, reduced ejection fraction, and a widened QRS complex, according to a ...

Pacemakers and other implantable devices that restore normal heart rhythms have saved millions of lives. In some patients, a pacemaker or implantable cardioverter defibrillator modified for "cardiac ...

Boston Scientific Corporation has launched COGNIS cardiac resynchronization therapy defibrillator (CRT-D) in the Chinese market. Professor Farong Shen in Zhejiang Lucheng Hospital and Professor Wei ...

New York, USA, Nov. 10, 2022 (GLOBE NEWSWIRE) -- The Global Cardiac Resynchronization Therapy Market is expected to Register an Immense Growth at a CAGR of 6.49% During the Forecast Period (2019–2027) ...